Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Patients' and physicians' roles in detecting recurrent Hodgkin lymphoma following complete remission.

Bestawros A, Foltz L, Srour N, Savage KJ, Connors JM.

Ann Oncol. 2013 May;24(5):1359-63. doi: 10.1093/annonc/mds606.

PMID:
23230136
2.

Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.

Dann EJ, Berkahn L, Mashiach T, Frumer M, Agur A, McDiarmid B, Bar-Shalom R, Paltiel O, Goldschmidt N.

Br J Haematol. 2014 Mar;164(5):694-700. doi: 10.1111/bjh.12687.

PMID:
24313286
3.

Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.

Friedmann AM, Wolfson JA, Hudson MM, Weinstein HJ, Link MP, Billett A, Larsen EC, Yock T, Donaldson SS, Marcus K, Krasin MJ, Howard SC, Metzger ML.

Pediatr Blood Cancer. 2013 Sep;60(9):1458-63. doi: 10.1002/pbc.24568.

4.

Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.

Truong Q, Shah N, Knestrick M, Curley B, Hu Y, Craig M, Hamadani M.

Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):50-5. doi: 10.1016/j.clml.2013.08.009.

PMID:
24119465
5.

Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.

El-Galaly TC, Mylam KJ, Bøgsted M, Brown P, Rossing M, Gang AO, Haglund A, Arboe B, Clausen MR, Jensen P, Pedersen M, Bukh A, Jensen BA, Poulsen CB, d'Amore F, Hutchings M.

Am J Hematol. 2014 Jun;89(6):575-80. doi: 10.1002/ajh.23688.

6.

Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer.

Agrawal A, deSilva BW, Buckley BM, Schuller DE.

Laryngoscope. 2004 Feb;114(2):232-5.

PMID:
14755196
8.

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma.

Sirohi B, Cunningham D, Powles R, Murphy F, Arkenau T, Norman A, Oates J, Wotherspoon A, Horwich A.

Ann Oncol. 2008 Jul;19(7):1312-9. doi: 10.1093/annonc/mdn052.

PMID:
18356139
9.

No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.

Jakobsen LH, Hutchings M, de Nully Brown P, Linderoth J, Mylam KJ, Molin D, Johnsen HE, Bøgsted M, Jerkeman M, El-Galaly TC.

Br J Haematol. 2016 Apr;173(2):236-44. doi: 10.1111/bjh.13943.

PMID:
26846879
10.

[FOLLOW-UP OF PATIENTS WITH CLASSICAL HODGIN LYMPHOMA AFTER TREATMENT--NOVEL EVIDENCE AND DILEMMAS. LITERATURE REVIEW].

Milunović V, Jakobac KM, Planinc-Peraica A, Kolonić SO.

Lijec Vjesn. 2016 Jan-Feb;138(1-2):47-53. Review. Croatian.

PMID:
27290814
11.

[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].

Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.

Ai Zheng. 2007 Dec;26(12):1360-4. Chinese.

PMID:
18076802
12.

A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.

Hodgson DC, Grunfeld E, Gunraj N, Del Giudice L.

Cancer. 2010 Jul 15;116(14):3417-25. doi: 10.1002/cncr.25053.

13.

The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.

Goldschmidt N, Or O, Klein M, Savitsky B, Paltiel O.

Ann Hematol. 2011 Feb;90(2):165-71. doi: 10.1007/s00277-010-1044-8.

PMID:
20706721
14.

An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.

Peethambaram P, Weiss M, Loprinzi CL, Novotny P, O'Fallon JR, Erlichman C, O'Connell MJ, Laurie JA.

Oncology. 1997 Jul-Aug;54(4):287-92.

PMID:
9216852
15.

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM.

Bone Marrow Transplant. 2001 Feb;27(4):387-96.

16.

Patterns of survival in patients with Hodgkin's disease: long follow up in a single centre.

Oza AM, Ganesan TS, Leahy M, Gregory W, Lim J, Dadiotis L, Barbounis V, Jones AE, Amess J, Stansfeld AG, et al.

Ann Oncol. 1993 May;4(5):385-92. Erratum in: Ann Oncol 1993 Sep;4(8):703.

PMID:
8353073
17.

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.

Czyz A, Lojko-Dankowska A, Dytfeld D, Nowicki A, Gil L, Matuszak M, Kozlowska-Skrzypczak M, Kazmierczak M, Bembnista E, Komarnicki M.

Med Oncol. 2013;30(3):611. doi: 10.1007/s12032-013-0611-y.

18.

Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre study.

Shamash J, Lee SM, Radford JA, Rohatiner AZ, Chang J, Morgenstern GR, Scarffe JH, Deakin DP, Lister TA.

Ann Oncol. 2000 Jun;11(6):715-9.

PMID:
10942061
19.

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

Schot BW, Zijlstra JM, Sluiter WJ, van Imhoff GW, Pruim J, Vaalburg W, Vellenga E.

Blood. 2007 Jan 15;109(2):486-91.

20.

The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.

Bilici A, Salman T, Oven Ustaalioglu BB, Unek T, Seker M, Aliustaoglu M, Gezen C, Unek T, Yavuzer D, Unlu M, Gumus M, Yilmaz U.

J Surg Res. 2013 Mar;180(1):e1-9. doi: 10.1016/j.jss.2012.03.035.

PMID:
22520575

Supplemental Content

Support Center